PREVALENCE AND MORTALITY RATE OF PROSTATE CANCER IN THE KYRGYZ REPUBLIC

Abstract

This article discusses the state of morbidity and fatality of patients with prostate carcinoma in the Kyrgyz Republic. It is identified, that there is high level of fatality along with low morbidity of prostate carcinoma. More than 2/3 of initially detected carriers of prostate carcinoma are registered in III-IV stage of neoplastic process. Introduction of prostate-specific antigen (PSA) in the country led to increase of the level of patients with I and II stage of illness. In Kyrgyzstan, there are all pre-conditions and possibilities for carrying out the screening of prostate carcinoma. Application of screening in Kyrgyzstan creates condition for active detection of patients with prostate carcinoma, in this turn it will lead to growth of number of patients with early stages of illness. Thus, in order to improve the results of treatment of prostate carcinoma, it is necessary to detect patients with early stages of prostate carcinoma. Therefor, this poses the question of active search of this category of patients.